Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Abemaciclib metabolite M18 | 2704316-81-2 | 98.0% | 1 ML
SDP

Catalog No. 5000342241
Encompass_Preferred

Abemaciclib metabolite M18 (LSN3106729), a metabolite of Abemaciclib, functions as a CDK inhibitor with antitumor activity. It can also be used with a CRBN ligand to engineer a PROTAC CDK4/6 degrader.

  • Functions as a CDK inhibitor.
  • Exhibits antitumor activity.
  • Used with a CRBN ligand to design a PROTAC CDK4/6 degrader.
  • Targets CDK4 and CDK6.
  • Inhibits retinoblastoma (RB) protein phosphorylation, inducing cell cycle arrest.
  • Promotes T-cell persistence and increased immunologic memory in mice.

Catalog No. 50-003-42241 Supplier Medchemexpress LLC Supplier No. HY126534A10MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Abemaciclib metabolite M18 (LSN3106729), a metabolite of Abemaciclib, functions as a CDK inhibitor with antitumor activity. It can also be used with a CRBN ligand to engineer a PROTAC CDK4/6 degrader.

  • Functions as a CDK inhibitor.
  • Exhibits antitumor activity.
  • Used with a CRBN ligand to design a PROTAC CDK4/6 degrader.
  • Targets CDK4 and CDK6.
  • Inhibits retinoblastoma (RB) protein phosphorylation, inducing cell cycle arrest.
  • Promotes T-cell persistence and increased immunologic memory in mice.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.